IDO1 and head and neck squamous cell carcinoma: SCC15 produced significantly more IDO than any of the six other cell lines. HNSCC cell lines from different hosts can have varying amounts of biomarkers. These differences could be due to the stage of disease, site of tumour, tissue type or genomic differences between patients. These results support personalised medicine in treating HNSCC